Richard Friedman to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Richard Friedman has written about Randomized Controlled Trials as Topic.
Connection Strength
0.231
-
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res. 2010 Sep; 126(3):175-82.
Score: 0.065
-
New oral anticoagulants for thromboprophylaxis after total hip or knee arthroplasty. Orthopedics. 2009 Dec; 32(12 Suppl):79-84.
Score: 0.063
-
Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty. Clin Appl Thromb Hemost. 2009 Sep-Oct; 15 Suppl 1:25S-31S.
Score: 0.062
-
Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Vasc Health Risk Manag. 2014; 10:157-67.
Score: 0.021
-
Scientific and ethical considerations in human clinical experimentation. South Med J. 1992 Sep; 85(9):917-22.
Score: 0.019